BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 788334)

  • 21. [The diagnosis and treatment of extensive cancer of the rectum].
    Faĭn SN; Inoiatov IM; Linetskaia LM
    Vopr Onkol; 1969; 15(12):93-8. PubMed ID: 5372978
    [No Abstract]   [Full Text] [Related]  

  • 22. [Mature dysembryoma of the ovary with epiploic diffusion of a differentiated peripheral nervous contingent].
    Casanova P; Laffargue F
    Arch Anat Pathol (Paris); 1975 Mar; 23(1):57-9. PubMed ID: 1155941
    [No Abstract]   [Full Text] [Related]  

  • 23. Importance of proper staging in ovarian carcinoma.
    Piver MS
    Clin Obstet Gynaecol; 1983 Aug; 10(2):223-34. PubMed ID: 6617038
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prognostic significance of cellular DNA content and AgNOR count in ovarian cystadenoma].
    Lu XL; Yi WM; Wang LF
    Ai Zheng; 2003 Jan; 22(1):62-5. PubMed ID: 12561439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between paraaortic lymph node involvement and intraperitoneal spread in patients with ovarian cancer--a multivariate analysis.
    Tsuruchi N; Kamura T; Tsukamoto N; Akazawa K; Saito T; Kaku T; To N; Nakano H
    Gynecol Oncol; 1993 Apr; 49(1):51-5. PubMed ID: 8482561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Abdominal carcinomatosis in women with a history of breast cancer.
    Garg R; Zahurak ML; Trimble EL; Armstrong DK; Bristow RE
    Gynecol Oncol; 2005 Oct; 99(1):65-70. PubMed ID: 15979132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppressive role of the metastasis-related nm23-H1 gene in human ovarian carcinomas: association of high messenger RNA expression with lack of lymph node metastasis.
    Viel A; Dall'Agnese L; Canzonieri V; Sopracordevole F; Capozzi E; Carbone A; Visentin MC; Boiocchi M
    Cancer Res; 1995 Jun; 55(12):2645-50. PubMed ID: 7780979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Two distinct patterns of peritoneal involvement shown by in vitro and in vivo ovarian cancer dissemination models.
    Kishikawa T; Sakamoto M; Ino Y; Kubushiro K; Nozawa S; Hirohashi S
    Invasion Metastasis; 1995; 15(1-2):11-21. PubMed ID: 7545653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Various types of Brenner tumor as a cell-differentiation majority of an ovarian mesothelioma. A case of Brenner tumor with "stromal" cells and metastases in the omentum].
    Costa A; Fedi A; Ogier E; Ottaviano M
    Arch De Vecchi Anat Patol; 1976 Aug; 61(2):371-97. PubMed ID: 1030610
    [No Abstract]   [Full Text] [Related]  

  • 30. Lymphatic metastases from the peritoneal cavity are increased in the postinflammatory state.
    Levine S; Saltzman A
    Invasion Metastasis; 1990; 10(5):281-8. PubMed ID: 2228516
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human ovarian carcinoma metastatic models constructed in nude mice by orthotopic transplantation of histologically-intact patient specimens.
    Fu X; Hoffman RM
    Anticancer Res; 1993; 13(2):283-6. PubMed ID: 8517640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Principles of staging laparotomy in ovarian cancer].
    Sevin BU; Graeff H
    Chirurg; 1994 Jan; 65(1):2-9. PubMed ID: 8149795
    [No Abstract]   [Full Text] [Related]  

  • 33. [Cutaneous metastases with calcospherites revealing an ovarian psammoma].
    Degos R; Bonvalet D; Belaïch S; Duterque M; Vallet C; Durupt G
    Ann Dermatol Syphiligr (Paris); 1973; 100(4):373-4. PubMed ID: 4770693
    [No Abstract]   [Full Text] [Related]  

  • 34. [A rare case of term pregnancy with histologically demonstrated metastases to the omentum of a papillary cystadenoma].
    Kichukova D; Milchev N
    Akush Ginekol (Sofiia); 1997; 36(2):43-4. PubMed ID: 9471905
    [No Abstract]   [Full Text] [Related]  

  • 35. [Case of ovarian neoplasm with neoplastic peritonitis surviving for 7 years after onset].
    Taki I
    Nihon Rinsho; 1968 Sep; 26(9):2116-20. PubMed ID: 5752285
    [No Abstract]   [Full Text] [Related]  

  • 36. Spontaneous regression of peritoneal carcinomatosis in a borderline ovarian tumour.
    Delotte J; Ferron G; Mery E; Gladieff L; Querleu D
    Eur J Obstet Gynecol Reprod Biol; 2009 Jan; 142(1):84-5. PubMed ID: 18986751
    [No Abstract]   [Full Text] [Related]  

  • 37. Molecular genetic evidence of an independent origin of serous low malignant potential implants and lymph node inclusions.
    Emerson RE; Wang M; Liu F; Lawrence WD; Abdul-Karim FW; Cheng L
    Int J Gynecol Pathol; 2007 Oct; 26(4):387-94. PubMed ID: 17885488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between pelvic lymph node involvement and other disease sites in patients with ovarian cancer.
    Sakai K; Kamura T; Hirakawa T; Saito T; Kaku T; Nakano H
    Gynecol Oncol; 1997 Apr; 65(1):164-8. PubMed ID: 9103407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Detection of tumor cells in the abdominal cavity in stomach cancer].
    Zybina MA
    Vopr Onkol; 1966; 12(6):21-6. PubMed ID: 4174749
    [No Abstract]   [Full Text] [Related]  

  • 40. [Palliative and second-look operations in ovarian cancer].
    Grünberger V; Dobrovits H; Hoffelner L
    Gynakol Rundsch; 1980 Jun; 20 Suppl 2():131-4. PubMed ID: 6163684
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.